The Safety Rates Drug Report

Member Login
2004.Q1    2004.Q2    2004.Q3    2004.Q4    2005.Q1    2005.Q2    2005.Q3    2005.Q4    2006.Q1    2006.Q2    2006.Q3    2006.Q4    2007.Q1    2007.Q2    2007.Q3    2007.Q4    2008.Q1    2008.Q2    2008.Q3    2008.Q4    2009.Q1    2009.Q2    2009.Q3    2009.Q4    2010.Q1    2010.Q2    2010.Q3    2010.Q4    2011.Q1    2011.Q2    2011.Q3    2011.Q4    2012.Q1    2012.Q2    2012.Q3    2012.Q4    2013.Q1    2013.Q2    2013.Q3    2013.Q4    2014.Q1    2014.Q2    2014.Q3    2014.Q4    2015.Q1    2015.Q2    2015.Q3    2015.Q4    2016.Q1    2016.Q2    2016.Q3   

Drug     Injury     Quarter    

Person who experienced the adverse event (patient)

Event ID CASEID CASEVERSION I F COD EVENT DT MFR DT INIT FDA DT FDA DT REPT COD AUTH NUM MFR NUM MFR SNDR LIT REF AGE AGE COD AGE GRP GNDR COD E SUB WT WT COD REPT DT TO MFR OCCP COD REPORTER COUNTRY OCCR COUNTRY
1042245726 10422457 26 F 201403 20160815 20140901 20160817 EXP PHHY2014CA040165 NOVARTIS 70.67 YR M Y 0.00000 20160817 CN COUNTRY NOT SPECIFIED CA

Drug(s) used by person

Event ID CASEID DRUG SEQ ROLE COD DRUGNAME PROD AI VAL VBM ROUTE DOSE VBM CUM DOSE CHR CUM DOSE UNIT DECHAL RECHAL LOT NUM EXP DT NDA NUM DOSE AMT DOSE UNIT DOSE FORM DOSE FREQ
1042245726 10422457 1 SS XOLAIR OMALIZUMAB 1 Subcutaneous 225 MG, BIW (EVERY 2 WEEKS) U 0 225 MG VIAL QOW
1042245726 10422457 2 SS XOLAIR OMALIZUMAB 1 Subcutaneous UNK U 0 VIAL
1042245726 10422457 3 SS XOLAIR OMALIZUMAB 1 Subcutaneous UNK U 0 VIAL
1042245726 10422457 4 SS XOLAIR OMALIZUMAB 1 Subcutaneous UNK U 0 VIAL
1042245726 10422457 5 SS XOLAIR OMALIZUMAB 1 Subcutaneous UNK U 0 VIAL
1042245726 10422457 6 SS XOLAIR OMALIZUMAB 1 Subcutaneous UNK U 0 VIAL
1042245726 10422457 7 SS XOLAIR OMALIZUMAB 1 Subcutaneous UNK U 0 VIAL
1042245726 10422457 8 SS XOLAIR OMALIZUMAB 1 Subcutaneous UNK U 0 VIAL
1042245726 10422457 9 SS XOLAIR OMALIZUMAB 1 Subcutaneous UNK U 0 VIAL
1042245726 10422457 10 SS XOLAIR OMALIZUMAB 1 Subcutaneous UNK U 0 VIAL
1042245726 10422457 11 SS XOLAIR OMALIZUMAB 1 Subcutaneous UNK U 0 VIAL
1042245726 10422457 12 SS XOLAIR OMALIZUMAB 1 Subcutaneous UNK U 0 VIAL
1042245726 10422457 13 SS XOLAIR OMALIZUMAB 1 Subcutaneous UNK U 0 VIAL
1042245726 10422457 14 SS XOLAIR OMALIZUMAB 1 Subcutaneous UNK U 0 VIAL
1042245726 10422457 15 SS XOLAIR OMALIZUMAB 1 Subcutaneous UNK U S0059B 0 VIAL
1042245726 10422457 16 SS XOLAIR OMALIZUMAB 1 Subcutaneous UNK U S0065E 0 VIAL
1042245726 10422457 17 SS XOLAIR OMALIZUMAB 1 Subcutaneous UNK U 0 VIAL
1042245726 10422457 18 SS XOLAIR OMALIZUMAB 1 Subcutaneous UNK U S0065E 0 VIAL
1042245726 10422457 19 SS XOLAIR OMALIZUMAB 1 Subcutaneous UNK U 0 VIAL
1042245726 10422457 20 SS XOLAIR OMALIZUMAB 1 Subcutaneous UNK U S0068D 0 VIAL
1042245726 10422457 21 SS XOLAIR OMALIZUMAB 1 Subcutaneous UNK U 0 VIAL
1042245726 10422457 22 PS DIOVAN HCT HYDROCHLOROTHIAZIDEVALSARTAN 1 Unknown Y 20818
1042245726 10422457 23 C SINGULAIR MONTELUKAST SODIUM 1 Unknown U 0
1042245726 10422457 24 C ADVAIR HFA FLUTICASONE PROPIONATESALMETEROL XINAFOATE 1 Unknown U 0
1042245726 10422457 25 C UNIPHYL THEOPHYLLINE ANHYDROUS 1 Unknown U 0
1042245726 10422457 26 C ALVESCO CICLESONIDE 1 Unknown U 0
1042245726 10422457 27 C AVELOX MOXIFLOXACIN HYDROCHLORIDE 1 Unknown U 0
1042245726 10422457 28 C SPIRIVA TIOTROPIUM BROMIDE MONOHYDRATE 1 Unknown U 0
1042245726 10422457 29 C VENTOLIN ALBUTEROL SULFATE 1 Unknown U 0
1042245726 10422457 30 C PREDNISONE. PREDNISONE 1 Oral U 0
1042245726 10422457 31 C PREDNISONE. PREDNISONE 1 Unknown 2 TIMES DURING A YEAR U 0
1042245726 10422457 32 C PREDNISONE. PREDNISONE 1 U 0

Indications of drugs used

Event ID CASEID INDI DRUG SEQ INDI PT
1042245726 10422457 1 Asthma
1042245726 10422457 22 Hypertension
1042245726 10422457 23 Product used for unknown indication
1042245726 10422457 24 Product used for unknown indication
1042245726 10422457 25 Product used for unknown indication
1042245726 10422457 26 Product used for unknown indication
1042245726 10422457 27 Product used for unknown indication
1042245726 10422457 28 Product used for unknown indication
1042245726 10422457 29 Product used for unknown indication
1042245726 10422457 30 Influenza
1042245726 10422457 31 Asthma
1042245726 10422457 32 Bronchitis

Outcome of event

Event ID CASEID OUTC COD
1042245726 10422457 HO
1042245726 10422457 OT

Reactions reported

Event ID CASEID DRUG REC ACT PT
1042245726 10422457 Abdominal pain upper
1042245726 10422457 Asthma
1042245726 10422457 Blood glucose abnormal
1042245726 10422457 Blood pressure increased
1042245726 10422457 Bronchitis
1042245726 10422457 Cough
1042245726 10422457 Influenza
1042245726 10422457 Peripheral swelling
1042245726 10422457 Pneumonia
1042245726 10422457 Road traffic accident
1042245726 10422457 Stress
1042245726 10422457 Throat irritation
1042245726 10422457 Weight decreased
1042245726 10422457 Weight increased

Reporting Sources (this data is often not reported and may therefore be missing here)

no results found

Therapies reported

Event ID CASEID DSG DRUG SEQ START DT END DT DUR DUR COD
1042245726 10422457 1 20130807 0
1042245726 10422457 2 20140508 0
1042245726 10422457 3 20140522 0
1042245726 10422457 4 20140828 0
1042245726 10422457 5 20141030 0
1042245726 10422457 6 20141113 0
1042245726 10422457 7 20141211 0
1042245726 10422457 8 20150108 0
1042245726 10422457 9 20150219 0
1042245726 10422457 10 20150304 0
1042245726 10422457 11 20150416 0
1042245726 10422457 12 20151015 0
1042245726 10422457 13 20151112 0
1042245726 10422457 14 20151126 0
1042245726 10422457 15 20160331 0
1042245726 10422457 16 20160418 0
1042245726 10422457 17 20160519 0
1042245726 10422457 18 20160613 0
1042245726 10422457 19 20160630 0
1042245726 10422457 20 20160802 0
1042245726 10422457 21 20160815 0
1042245726 10422457 22 201408 0

Execution Time: 0.0094449520111084 seconds (ucode:5047570). Developed by: James D. Barger

 


another James Barger innovation
All original content on this site is © 2013-2024 James D. Barger and SafetyRates.com.